(French) : Les bienfaits d’une nouvelle molécule dans l'angioplastie coronaire

These contents could be interesting :

Resistance mutations to nirsevimab are rare in respiratory syncytial virus (RSV)

Nirsevimab is an antibody targeting the respiratory syncytial virus (RSV). Available in France since September 2023, it is indicated in neonates and infants for the prevention of bronchiolitis caused....

Hyperglycémie : vers une meilleure compréhension de son impact délétère sur la peau

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment.....

Medias

Researcher Contact

Professeur Gabriel StegDépartement de Cardiologie, Hôpital Bichat Tél: 01 40 25 86 68 courriel: tnoevry.fgrt@opu.ncuc.se

Press Contact

APHPClémence Rémy 01 40 27 37 22 freivpr.cerffr@fnc.ncuc.se

Sources

Steg PG, Bhatt DL, Hamm CW et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. The Lancet 2013

Inserm Newsroom - Press room of the French national institute of health and medical research

(French) : Les bienfaits d’une nouvelle molécule dans l’angioplastie coronaire

These contents could be interesting :

Resistance mutations to nirsevimab are rare in respiratory syncytial virus (RSV)

Hyperglycémie : vers une meilleure compréhension de son impact délétère sur la peau

Researcher Contact

Press Contact